Convergent adaptation of human lactase persistence in Africa and Europe SA Tishkoff, FA Reed, A Ranciaro, BF Voight, CC Babbitt, JS Silverman, ... Nature genetics 39 (1), 31-40, 2007 | 1875 | 2007 |
The genetic structure and history of Africans and African Americans SA Tishkoff, FA Reed, FR Friedlaender, C Ehret, A Ranciaro, A Froment, ... science 324 (5930), 1035-1044, 2009 | 1846 | 2009 |
In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project RS Judson, KA Houck, RJ Kavlock, TB Knudsen, MT Martin, ... Environmental health perspectives 118 (4), 485-492, 2010 | 609 | 2010 |
Whole-mtDNA genome sequence analysis of ancient African lineages MK Gonder, HM Mortensen, FA Reed, A de Sousa, SA Tishkoff Molecular biology and evolution 24 (3), 757-768, 2007 | 373 | 2007 |
History of click-speaking populations of Africa inferred from mtDNA and Y chromosome genetic variation SA Tishkoff, MK Gonder, BM Henn, H Mortensen, A Knight, C Gignoux, ... Molecular biology and evolution 24 (10), 2180-2195, 2007 | 302 | 2007 |
African Y chromosome and mtDNA divergence provides insight into the history of click languages A Knight, PA Underhill, HM Mortensen, LA Zhivotovsky, AA Lin, BM Henn, ... Current Biology 13 (6), 464-473, 2003 | 242 | 2003 |
Native American mtDNA prehistory in the American southwest RS Malhi, HM Mortensen, JA Eshleman, BM Kemp, JG Lorenz, FA Kaestle, ... American Journal of Physical Anthropology: The Official Publication of the …, 2003 | 160 | 2003 |
Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets TB Knudsen, KA Houck, NS Sipes, AV Singh, RS Judson, MT Martin, ... Toxicology 282 (1-2), 1-15, 2011 | 157 | 2011 |
AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks ME Pittman, SW Edwards, C Ives, HM Mortensen Toxicology and applied pharmacology 343, 71-83, 2018 | 79 | 2018 |
Accelerating adverse outcome pathway development using publicly available data sources NO Oki, MD Nelms, SM Bell, HM Mortensen, SW Edwards Current environmental health reports 3, 53-63, 2016 | 63 | 2016 |
Characterization of Genetic Variation and Natural Selection at the Arylamine N-Acetyltransferase Genes in Global Human Populations HM Mortensen, A Froment, G Lema, JM Bodo, M Ibrahim, TB Nyambo, ... Pharmacogenomics 12 (11), 1545-1558, 2011 | 49 | 2011 |
Integrating mechanistic and polymorphism data to characterize human genetic susceptibility for environmental chemical risk assessment in the 21st century HM Mortensen, SY Euling Toxicology and applied pharmacology 271 (3), 395-404, 2013 | 33 | 2013 |
Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment HM Mortensen, J Chamberlin, B Joubert, M Angrish, N Sipes, JS Lee, ... Mammalian genome 29, 190-204, 2018 | 24 | 2018 |
The 2021 update of the EPA’s adverse outcome pathway database HM Mortensen, J Senn, T Levey, P Langley, AJ Williams Scientific Data 8 (1), 169, 2021 | 19 | 2021 |
Using pathway modules as targets for assay development in xenobiotic screening RS Judson, HM Mortensen, I Shah, TB Knudsen, F Elloumi Molecular BioSystems 8 (2), 531-542, 2012 | 18 | 2012 |
COVID-19 through adverse outcome pathways: Building networks to better understand the disease–3rd CIAO AOP design workshop LA Clerbaux, N Amigó, MJ Amorim, A Bal-Price, SB Leite, A Beronius, ... Altex 39 (2), 322–335, 2022 | 16 | 2022 |
The AOP-DB RDF: Applying FAIR principles to the semantic integration of AOP data using the research description framework HM Mortensen, M Martens, J Senn, T Levey, CT Evelo, EL Willighagen, ... Frontiers in Toxicology 4, 803983, 2022 | 10 | 2022 |
An EPA database on the effects of engineered nanomaterials-NaKnowBase WK Boyes, B Beach, G Chan, BLM Thornton, P Harten, HM Mortensen Scientific Data 9 (1), 12, 2022 | 8 | 2022 |
A community-driven, openly accessible molecular pathway integrating knowledge on malignant pleural mesothelioma M Martens, F Kreidl, F Ehrhart, D Jean, M Mei, HM Mortensen, A Nash, ... Frontiers in oncology 12, 849640, 2022 | 5 | 2022 |
Why adverse outcome pathways need to be FAIR C Wittwehr, LA Clerbaux, S Edwards, M Angrish, H Mortensen, A Carusi, ... ALTEX 41 (1), 50, 2024 | 3 | 2024 |